288 related articles for article (PubMed ID: 580305)
1. Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis.
Izumi M; Larsen PR
Metabolism; 1978 Apr; 27(4):449-60. PubMed ID: 580305
[TBL] [Abstract][Full Text] [Related]
2. Serum free thyroxine and triiodothyronine concentrations in subacute thyroiditis.
Yoshida K; Sakurada T; Kaise N; Kaise K; Kitaoka H; Fukazawa H; Yamamoto M; Saito S; Yoshinaga K
J Clin Endocrinol Metab; 1982 Jul; 55(1):185-8. PubMed ID: 6176591
[TBL] [Abstract][Full Text] [Related]
3. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
[TBL] [Abstract][Full Text] [Related]
4. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K
Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311
[TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis.
Kojima N; Sakata S; Nakamura S; Nagai K; Takuno H; Ogawa T; Matsui I; Sarui H; Miura K
J Endocrinol Invest; 1992; 15(7):491-6. PubMed ID: 1447487
[TBL] [Abstract][Full Text] [Related]
6. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
[TBL] [Abstract][Full Text] [Related]
7. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
Larsen PR
J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte carbonic anhydrase-I concentrations in patients with Graves' disease and subacute thyroiditis reflect integrated thyroid hormone levels over the previous few months.
Kiso Y; Yoshida K; Kaise K; Kaise N; Fukazawa H; Mori K; Abe K; Yoshinaga K
J Clin Endocrinol Metab; 1991 Feb; 72(2):515-8. PubMed ID: 1899425
[TBL] [Abstract][Full Text] [Related]
9. Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease.
Takamatsu J; Sugawara M; Kuma K; Kobayashi A; Matsuzuka F; Mozai T; Hershman JM
Ann Intern Med; 1984 Mar; 100(3):372-5. PubMed ID: 6546484
[TBL] [Abstract][Full Text] [Related]
10. Identification of thyroid hormone residues on serum thyroglobulin: a clue to the source of circulating thyroglobulin in thyroid diseases.
Druetta L; Bornet H; Sassolas G; Rousset B
Eur J Endocrinol; 1999 May; 140(5):457-67. PubMed ID: 10229914
[TBL] [Abstract][Full Text] [Related]
11. Serum thyroglobulin changes in patients with Graves' disease treated with long term antithyroid drug therapy.
Kawamura S; Kishino B; Tajima K; Mashita K; Tarui S
J Clin Endocrinol Metab; 1983 Mar; 56(3):507-12. PubMed ID: 6185525
[TBL] [Abstract][Full Text] [Related]
12. [Clinical studeis on the regulatory system of thyroid hormone secretion and serum triiodothyronine. Part III. Studies on thyroid hormone change and its relationship when TSH in cases with subclinical hypothyroidism (Hashimoto's thyroiditis and 131I treated Graves' disease)].
Takeda Y
Nihon Naibunpi Gakkai Zasshi; 1975 Feb; 51(2):85-97. PubMed ID: 808432
[TBL] [Abstract][Full Text] [Related]
13. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
Izumi M; Larsen PR
J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211
[TBL] [Abstract][Full Text] [Related]
14. Serum thyroglobulin concentration as an indicator for assessing thyroid stimulation in patients with Graves' disease during antithyroid drug therapy.
Aizawa T; Ishihara M; Koizumi Y; Hashizume K; Takasu N; Yamada T; Kobayashi I; Watanabe T; Shimizu Z
Am J Med; 1990 Aug; 89(2):175-80. PubMed ID: 2166430
[TBL] [Abstract][Full Text] [Related]
15. Serum autotaxin levels are associated with Graves' disease.
Nojiri T; Kurano M; Araki O; Nakawatari K; Nishikawa M; Shimamoto S; Igarashi K; Kano K; Aoki J; Kihara S; Murakami M; Yatomi Y
Endocr J; 2019 May; 66(5):409-422. PubMed ID: 30814442
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of corticosteroids on thyroid activity in Graves' disease.
Williams DE; Chopra IJ; Orgiazzi J; Solomon DH
J Clin Endocrinol Metab; 1975 Aug; 41(2):354-61. PubMed ID: 1174132
[TBL] [Abstract][Full Text] [Related]
17. T3 toxicosis in children.
Harland PC; McArthur RG; Fawcett DM
Acta Paediatr Scand; 1977 Jul; 66(4):525-8. PubMed ID: 578375
[TBL] [Abstract][Full Text] [Related]
18. Incomplete thyrotroph suppression determined by third generation thyrotropin assay in subacute thyroiditis compared to silent thyroiditis or hyperthyroid Graves' disease.
Ito M; Takamatsu J; Yoshida S; Murakami Y; Sakane S; Kuma K; Ohsawa N
J Clin Endocrinol Metab; 1997 Feb; 82(2):616-9. PubMed ID: 9024264
[TBL] [Abstract][Full Text] [Related]
19. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease.
Amino N; Yabu Y; Miyai K; Fujie T; Azukizawa M; Onishi T; Kumahara Y
Lancet; 1978 Aug; 2(8085):344-6. PubMed ID: 79711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
